Fiji vs Yemen: Previously treated cases tested for RR-/MDR-TB
Fiji
100.0%
in 2024
Yemen
100.0%
in 2024
Fiji rank
1st
Yemen rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Fiji
- Yemen
How they compare
Fiji currently reports 100.0% against 100.0% in Yemen, a difference of 0.0%.
The two have swapped places 9 times across 16 shared years of data; in 2006 it was Fiji ahead.
Fiji ranks 1st and Yemen ranks 1st of 180 countries.
Fiji has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Fiji | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 66.7% | 10.2% | 56.5% | Fiji |
| 2010s | 47.6% | 21.5% | 26.2% | Fiji |
| 2020s | 81.8% | 60.0% | 21.8% | Fiji |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Fiji or Yemen?
- Fiji, at 100.0% against 100.0% in Yemen as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Fiji and Yemen?
- 0.0%, with Fiji ahead.
- How many years of comparable data are there for Fiji and Yemen?
- 16 years are reported by both, from 2006 to 2024.
- How do Fiji and Yemen rank globally for previously treated cases tested for rr-/mdr-tb?
- Fiji ranks 1st and Yemen ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.